Lumiquick Diagnostics, Inc.


Lumiquick Diagnostics Inc., located in Silicon Valley, California, develops, manufactures, and markets high-quality point of care tests and immunoassay kits for the global in vitro diagnostic market. Their extensive product lines include rapid tests for infectious diseases, cancer markers, cardiac markers, drugs of abuse, fertility hormones, and other disease markers, many of which are CE marked and registered internationally. Their mission is to provide high-quality, affordable products to help combat human diseases and illicit substance abuse worldwide, with a commitment to exceptional quality and customer service.

Industries

health-diagnostics
manufacturing
medical-device
test-and-measurement

Nr. of Employees

small (1-50)

Lumiquick Diagnostics, Inc.

Santa Clara, California, United States, North America


Products

Rapid lateral-flow infectious disease tests

Point-of-care lateral-flow immunoassays for antigen or antibody detection across a broad infectious disease portfolio (respiratory, tropical, hemorrhagic, gastro-intestinal, hepatitis, HIV, STDs) with specified specimen types and read times.

Drugs-of-abuse rapid tests and multi-panel screens

Immunochromatographic test strips, cards and cups for single-drug and multi-panel drugs-of-abuse screening in urine or saliva; CLIA-waived configurations available for some panel formats.

ELISA/EIA microplate kits for clinical and research markers

Microplate-based enzyme immunoassays for hormonal, metabolic, inflammatory, autoimmune, cancer and infectious disease analytes with 48/96-well kit formats.

Oxidative stress and biomarker assay kits

Colorimetric and EIA microplate kits targeting oxidative stress markers (glutathione, nitric oxide, MDA, 8-OHdG), DNA damage and related biomarkers for human and animal samples.

Veterinary diagnostic and food-safety rapid tests

Rapid antigen and antibody tests for companion animals and production animals plus food-safety assays for toxins and antibiotic residues in food/milk matrices.

Bio-threat presumptive detection kits

On-site presumptive lateral-flow assays for selected biological threat agents and associated training kits for operator familiarization.

View All Products

Services

OEM and private-label manufacturing

Manufacture and packaging of finished diagnostic kits or bulk product for third-party labeling; customization of panel combinations and packaging.

Product development and feasibility studies

Feasibility assessment and development support for new immunoassay products, including reagent pairing and prototype development.

Training kits and technical documentation

Provision of training kits for selected assays and downloadable instructions for use (IFU), product flyers and technical datasheets.

Distribution and sales support for diagnostic products

Management of commercial distribution channels, including exclusive regional distribution arrangements and customer service/order processing.

Expertise Areas

  • Point-of-care diagnostics
  • Immunoassay development
  • Lateral-flow assay manufacturing
  • ELISA/EIA kit development
  • Show More (6)

Key Technologies

  • Lateral flow immunochromatography (rapid tests)
  • Enzyme-linked immunosorbent assay (ELISA/EIA)
  • RT-PCR (SARS-CoV-2 RT-PCR kits)
  • Colorimetric microplate assays
  • Show More (3)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.